IBDEI10Q ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17277,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,17277,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,17278,0)
 ;;=B19.10^^73^832^18
 ;;^UTILITY(U,$J,358.3,17278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17278,1,3,0)
 ;;=3^Hepatitis B,Viral Unspec
 ;;^UTILITY(U,$J,358.3,17278,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,17278,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,17279,0)
 ;;=B17.10^^73^832^2
 ;;^UTILITY(U,$J,358.3,17279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17279,1,3,0)
 ;;=3^Acute Hepatitis C w/o hepatic coma
 ;;^UTILITY(U,$J,358.3,17279,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,17279,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,17280,0)
 ;;=B18.2^^73^832^21
 ;;^UTILITY(U,$J,358.3,17280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17280,1,3,0)
 ;;=3^Hepatitis C,Viral,Chronic
 ;;^UTILITY(U,$J,358.3,17280,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,17280,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,17281,0)
 ;;=E05.90^^73^832^28
 ;;^UTILITY(U,$J,358.3,17281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17281,1,3,0)
 ;;=3^Hyperthyroidism w/o Thyrotoxic Crisis/Storm,Unspec
 ;;^UTILITY(U,$J,358.3,17281,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,17281,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,17282,0)
 ;;=E03.9^^73^832^34
 ;;^UTILITY(U,$J,358.3,17282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17282,1,3,0)
 ;;=3^Hypothyroidism, unspec
 ;;^UTILITY(U,$J,358.3,17282,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,17282,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,17283,0)
 ;;=E16.2^^73^832^31
 ;;^UTILITY(U,$J,358.3,17283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17283,1,3,0)
 ;;=3^Hypoglycemia, unspec
 ;;^UTILITY(U,$J,358.3,17283,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,17283,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,17284,0)
 ;;=E78.0^^73^832^24
 ;;^UTILITY(U,$J,358.3,17284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17284,1,3,0)
 ;;=3^Hypercholesterolemia,Pure
 ;;^UTILITY(U,$J,358.3,17284,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,17284,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,17285,0)
 ;;=E78.0^^73^832^29
 ;;^UTILITY(U,$J,358.3,17285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17285,1,3,0)
 ;;=3^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,17285,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,17285,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,17286,0)
 ;;=E78.5^^73^832^26
 ;;^UTILITY(U,$J,358.3,17286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17286,1,3,0)
 ;;=3^Hyperlipidemia, unspec
 ;;^UTILITY(U,$J,358.3,17286,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,17286,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,17287,0)
 ;;=E87.1^^73^832^30
 ;;^UTILITY(U,$J,358.3,17287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17287,1,3,0)
 ;;=3^Hypo-osmolality and hyponatremia
 ;;^UTILITY(U,$J,358.3,17287,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,17287,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,17288,0)
 ;;=E87.5^^73^832^25
 ;;^UTILITY(U,$J,358.3,17288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17288,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,17288,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,17288,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,17289,0)
 ;;=E87.6^^73^832^32
 ;;^UTILITY(U,$J,358.3,17289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17289,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,17289,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,17289,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,17290,0)
 ;;=G81.91^^73^832^11
 ;;^UTILITY(U,$J,358.3,17290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17290,1,3,0)
 ;;=3^Hemiplegia affecting rt dominant side, unspec
 ;;^UTILITY(U,$J,358.3,17290,1,4,0)
 ;;=4^G81.91
 ;;^UTILITY(U,$J,358.3,17290,2)
 ;;=^5004121
